HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After Quiet Start, Optigenex Looks To Make Noise As Anti-Aging Brand

This article was originally published in The Rose Sheet

Executive Summary

Optigenex got started in business largely as a silent supplier for beauty giant Estee Lauder, but the firm now is making itself known as a developer of anti-aging skin-care and supplement ingredients that stimulate DNA repair

You may also be interested in...



Optigenex/Promethean

Hoboken, N.J.-based ingredient developer and New York manufacturer expand terms of their licensing deal, allowing Promethean to market ingestible and topical cosmeceutical products containing Optigenex's proprietary AC-11 technology in broader markets worldwide, excluding Japan and Turkey. To date, Promethean has been largely restricted to North American distribution channels. "From the start last year, our company's association with Promethean and [its subsidiary] Ceres Living has been special. Finding a way to expand our interactions into something more akin to a product development and marketing partnership than a supplier-customer relationship was something we [identified as] a priority goal," says Optigenex President and CEO Daniel Zwiren. AC-11, extracted from the Uncaria tomentosa plant in the Brazilian rainforest, is touted as a unique ingredient that assists in the repair of DNA damaged by sun exposure and other factors. For five years, Optigenex supplied the active to the Estee Lauder Companies for use in its skin-care products (1"The Rose Sheet" April 12, 2010)

Optigenex/Promethean

Hoboken, N.J.-based ingredient developer and New York manufacturer expand terms of their licensing deal, allowing Promethean to market ingestible and topical cosmeceutical products containing Optigenex's proprietary AC-11 technology in broader markets worldwide, excluding Japan and Turkey. To date, Promethean has been largely restricted to North American distribution channels. "From the start last year, our company's association with Promethean and [its subsidiary] Ceres Living has been special. Finding a way to expand our interactions into something more akin to a product development and marketing partnership than a supplier-customer relationship was something we [identified as] a priority goal," says Optigenex President and CEO Daniel Zwiren. AC-11, extracted from the Uncaria tomentosa plant in the Brazilian rainforest, is touted as a unique ingredient that assists in the repair of DNA damaged by sun exposure and other factors. For five years, Optigenex supplied the active to the Estee Lauder Companies for use in its skin-care products (1"The Rose Sheet" April 12, 2010)

Promethean Fires Up AC-11 Cosmeceutical Line With Optigenex Deal

Promethean Corporation aims to launch nutritional supplements and a topical skin-care system in 2010 under a deal with Optigenex granting it access to the latter's AC-11 compound for DNA repair

Related Content

UsernamePublicRestriction

Register

RS016843

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel